Lucid Diligence Brief: Neurogen Biomarking and Tasso partnership for at-home Alzheimer’s blood collection
Lucid Diligence Brief: Neurogen Biomarking and Tasso partnership for at-home…
Lucid Diligence Brief: WellBeam $10M Series A
Lucid Diligence Brief: WellBeam $10M Series A Professional audiences only. Not…
Lucid Diligence Brief: Abbott to acquire Exact Sciences
Lucid Diligence Brief: Abbott to acquire Exact Sciences Professional audiences…
Lucid Diligence Brief: Tempest Therapeutics and Factor Bioscience dual-CAR T deal
Lucid Diligence Brief: Tempest Therapeutics and Factor Bioscience dual-CAR T…
Lucid Diligence Brief: Avanzanite Bioscience €32m Series A
Lucid Diligence Brief: Avanzanite Bioscience €32m Series A Professional…
Lucid Diligence Brief: Merck to acquire Cidara Therapeutics
Lucid Diligence Brief: Merck to acquire Cidara Therapeutics Professional…
Lucid Diligence Brief: Beacon Biosignals $86M Series B to scale its AI-EEG platform
Lucid Diligence Brief: Beacon Biosignals $86M Series B to scale its AI-EEG…
Lucid Diligence Brief: myTomorrows $29 million funding to scale AI-enabled clinical-trial recruitment
Lucid Diligence Brief: myTomorrows $29 million funding to scale AI-enabled…
Lucid Diligence Brief: Iambic raises $100M+ for AI drug discovery
Lucid Diligence Brief: Iambic raises $100M+ for AI drug discovery Professional…
Lucid Diligence Brief: Amae Health $25M Series B
Lucid Diligence Brief: Amae Health $25M Series B Professional audiences only.…
Lucid Diligence Brief: Manifold Bio and Roche brain-shuttle collaboration
Lucid Diligence Brief: Manifold Bio and Roche brain-shuttle collaboration…
Lucid Diligence Brief: Thermo Fisher to acquire Clario
Lucid Diligence Brief: Thermo Fisher to acquire Clario Professional audiences…